Before
This page outlines Medinet's management policy and strategy. Founded in 1999, the company processes cells for immunotherapy and operates the Shinagawa CPF facility near Haneda Airport. The facility holds permits for manufacturing specified cell-processed products and regenerative medicine products. Medinet aims to leverage its strengths and expand into new business areas including cell processing for companies and CDMO services. The company targets early profitability and accelerated growth through regenerative medicine product development. Long-term, it pursues "VISION2030," aiming to become a Healthcare Innovating Company contributing to a Well-Being society through health improvement and disease treatment.
